metabolic profiling of Parkinson's disease and mild cognitive impairment
Movement Disorders2017Vol. 32(6), pp. 927–932
Citations Over TimeTop 10% of 2017 papers
Florence Burté, David Houghton, Hannah Lowes, Angela Pyle, Sarah Nesbitt, Alison J. Yarnall, Patrick Yu‐Wai‐Man, David J. Burn, Mauro Santibanez‐Koref, Gavin Hudson
Abstract
Our study indicates that fatty acid oxidation may be an important component in the pathophysiology of Parkinson's disease and may have potential as a diagnostic biomarker for disease onset and mild cognitive impairment. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Related Papers
- → A comparison of screening tools for the assessment of Mild Cognitive Impairment: Preliminary findings(2011)51 cited
- The application of Montreal cognitive assessment Scale (Changsha version) in diagnosis of elderly patients with mild cognitive impairment(2014)
- → The test accuracy of the montreal cognitive assessment (MoCA) in stroke(2017)2 cited
- Preliminary study of cognition assessment by Montreal Cognitive Assessment Scale in the patients with vascular mild cognitive impairment(2011)
- → 89Comparison Study of The Montreal Cognitive Assessment(MoCA-CN) and The Quick Mild Cognitive Impairment Screen (Qmci-CN) in Post-Stroke Patients(2018)